Serologically predicting direct oral anticoagulant failure with antiphospholipid antibodies
Authors:
- 2 January 2020
- journal article
- letter
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 18 (1) , 258-259
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndromeBlood, 2018
- The use of direct oral anticoagulants in 56 patients with antiphospholipid syndromeThrombosis Research, 2017
- Antithrombotic Therapy for VTE DiseaseChest, 2016
- Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trialsBlood, 2014
- The ASH Choosing Wisely® campaign: five hematologic tests and treatments to questionBlood, 2013
- Estimated Frequency of Antiphospholipid Antibodies in Patients With Pregnancy Morbidity, Stroke, Myocardial Infarction, and Deep Vein Thrombosis: A Critical Review of the LiteratureArthritis Care & Research, 2013
- A novel mechanism of thrombosis in antiphospholipid antibody syndromeJournal of Autoimmunity, 2010